国际免疫耐受诱导研究中因极低滴度抑制物存在导致的耐受受损
该研究纳入115例伴抑制物的血友病A患者,其中53例在同一批175个时间点样本上同时用Nijmegen改良Bethesda法(NBA)和Nijmegen超敏感Bethesda法(NusBA)检测抑制物。NusBA与FVIII半衰期的相关性(r=-.56)强于NBA(r=-.36),NusBA的曲线下面积(0.79)高于NBA(0.64)。免疫耐受诱导后NusBA阳性样本占66%,而NBA阳性仅占42%。
要点
- NusBA与FVIII半衰期相关性(r=-.56)强于NBA(r=-.36)。
- 以FVIII半衰期≥7小时为耐受指标,NusBA的AUC为0.79,高于NBA的0.64。
- 免疫耐受诱导后NusBA阳性样本66%,NBA阳性样本42%。
核心结论
- NusBA可检测极低滴度抑制物,在免疫耐受诱导后早期与FVIII半衰期相关。
- NusBA对接受免疫耐受诱导的血友病A伴抑制物患者监测耐受具有附加价值。
研究设计与样本
- 国际免疫耐受诱导研究,纳入115例伴抑制物的血友病A患者(pwHAI)。
- 其中53例参与者的同一批样本在175个时间点同时用NBA和NusBA检测。
- 175次同步测量中有50次包含药代动力学分析,用于将FVIII半衰期和回收率与NBA、NusBA结果进行相关性分析并绘制受试者工作特征曲线。
主要发现
- NusBA与FVIII半衰期的相关性(r=-.56;95%CI,-.80至-.20;P=.004)强于NBA(r=-.36;95%CI,-.67至-.06;P=.008)。
- 以FVIII半衰期≥7小时指示耐受时,NusBA的曲线下面积为0.79(95%CI,0.59-0.98),高于NBA的0.64(95%CI,0.40-0.87)。
- NBA无法检测出FVIII半衰期降低的pwHAI中的极低滴度抑制物水平。
- 免疫耐受诱导后,所有样本中NusBA阳性占66%,NBA阳性占42%。
临床怎么用
- 原文结论指出NusBA对接受免疫耐受诱导的pwHAI监测耐受具有附加价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In persons with hemophilia A (pwHA), development of an inhibitor complicates treatment with factor (F)VIII replacement therapy. Immune tolerance induction (ITI) is used to restore tolerance. However, some pwHA do not reach tolerance despite disappearance of the inhibitor detected with the Nijmegen-modified Bethesda assay (NBA), potentially due to the persistent presence of very low-titer inhibitors. OBJECTIVES: We determined the presence of very low-titer inhibitors with the Nijmegen ultrasensitive Bethesda assay (NusBA) in the International-ITI study. METHODS: This study included 115 pwHA with inhibitors (pwHAI). In 53 of these participants, both NBA and NusBA were determined from the same sample measured at 175 time points. Both FVIII half-life and recovery were correlated with NBA and NusBA results, which were used to plot receiver operating characteristic curves, as 50 of 175 concurrent measurements included pharmacokinetic analysis. RESULTS: NusBA had a stronger correlation with FVIII half-life (r = -.56; 95% CI, -.80 to -.20; P = .004) than NBA (r = -.36; 95% CI, -.67 to -.06; P = .008). Also, the area under the curve of the NusBA (0.79; 95% CI, 0.59-0.98) was higher than the area under the curve of the NBA (0.64; 95% CI, 0.40-0.87), with FVIII half-life of ≥7 hours, indicating tolerance. The NBA was unable to detect very low-titer inhibitor levels in pwHAI with a decreased FVIII half-life. Post-ITI, a positive NusBA was detected in 66% of all samples, which is in contrast to the 42% NBA-positive samples. CONCLUSION: The NusBA can detect very low-titer inhibitors and correlates with FVIII half-life in the early post-ITI period. The NusBA has added value in pwHAI undergoing ITI to monitor tolerance.
引用
- Valke LLFG, Hay CRM, DiMichele DM, et al. Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitors. J Thromb Haemost. 2025. PMID: 40701257. doi:10.1016/j.jtha.2025.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。